Table 2.
Comparison of the complications, treatments, and outcomes of survivors and non-survivors
| Survivor at 28 days after PICU admission (n = 90) | Non-survivors at 28 days after PICU admission (n = 57) | p Value | |
|---|---|---|---|
| Complications during PICU stay; n (%) | |||
| Cardiovascular dysfunction | 48 (55) | 46 (77) | <0.01 |
| Hepatic dysfunction | 5 (6) | 7 (12) | 0.21 |
| Renal dysfunction | 10 (11) | 20 (35) | <0.01 |
| Hematologic dysfunction | 6 (7) | 16 (28) | <0.01 |
| Barotrauma | 11 (13) | 16 (28) | 0.03 |
| Ventilation-associated pneumonia | 15 (17) | 13 (23) | 0.54 |
| Acute respiratory distress syndrome | 59 (65) | 53 (93) | <0.01 |
| Treatments; n (%) | |||
| Antibiotic | 89 (99) | 54 (95) | 0.3 |
| Oseltamivir | 83 (92) | 52 (91) | 1 |
| Oseltamivir ≤24 h | 77 (86) | 39 (68) | 0.01 |
| Inotropes or vasopressors | 56 (62) | 49 (86) | <0.01 |
| Outcomes; days, median (IQR) | |||
| Length of mechanical ventilation | 11.5 (6–22) | 8 (3–15) | 0.01 |
| Length of stay in the hospital | 19 (13–31) | 12 (5–19) | <0.01 |
| Length of stay in the PICU | 12 (8–25) | 8 (3–15.5) | <0.01 |